Form 4: Zynex Inc. CEO Thomas Sandgaard Sells 2,000 Shares Under 10b5-1 Trading Plan

Zynex Inc.'s CEO, Thomas Sandgaard, sold 2,000 shares of common stock at an average price of $8.09 per share, according to a recent SEC Form 4 filing.

Summary

• Thomas Sandgaard, the President, CEO, and Chairman of Zynex Inc., sold 2,000 shares of common stock on November 14, 2024.
• The sale was executed at a weighted average price of $8.09 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on July 31, 2024.
• Following the transaction, Sandgaard directly owns 14,603,662 shares of Zynex Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to a pre-planned stock sale by an executive. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice among corporate executives to manage their stock sales in compliance with insider trading regulations.
• Similar filings are regularly made by executives at other publicly traded companies, such as Medtronic (MDT) and Stryker (SYK), when they execute pre-planned stock sales.

Stakeholder Impact

• The stock sale may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small number of shares sold and the pre-planned nature of the transaction.

Key Dates

Keywords

Zynex Inc, Thomas Sandgaard, SEC Form 4, stock sale, Rule 10b5-1, insider trading, ZYXI